Seeing Is Believing
with an average price target of $30.91. This is a potential upside of $30.91 (0%) from yesterday's end of day stock price of $0.
Genocea Biosciences's activity chart (see below) currently has 32 price targets and 32 ratings on display.
Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 32.1 days.
Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 28-Apr-2022. First documented stock forecast 04-Mar-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
3 years 5 months 24 days ago
(28-Apr-2022)
0/2 (0%)
$10 (100.00%)
Hold
$0.16
$0.16 (0.00%)
$18
3 years 5 months 24 days ago
(28-Apr-2022)
1/3 (33.33%)
$-0.12 (-42.86%)
25
Hold
$9
3 years 5 months 24 days ago
(28-Apr-2022)
1/2 (50%)
$5.4 (150.00%)
4
Buy
4 years 8 months 12 days ago
(10-Feb-2021)
0/1 (0%)
$9.91 (162.73%)
Buy
$8
$8 (0.00%)
$15
5 years 2 months 23 days ago
(29-Jul-2020)
0/2 (0%)
$4.55 (131.88%)
What is GNCA (Genocea Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on GNCA (Genocea Biosciences) with a proven track record?
Which analyst has the most public recommendations on GNCA (Genocea Biosciences)?
Which analyst is the currently most bullish on GNCA (Genocea Biosciences)?
Which analyst is the currently most reserved on GNCA (Genocea Biosciences)?